Repligen Corp (NASDAQ: RGEN) kicked off on Tuesday, up 5.34% from the previous trading day, before settling in for the closing price of $145.66. Over the past 52 weeks, RGEN has traded in a range of $102.96-$182.52.
While this was happening, its average annual earnings per share was recorded 5.49%. With a float of $53.19 million, this company’s outstanding shares have now reached $56.28 million.
The firm has a total of 1778 workers. Let’s measure their productivity.
Repligen Corp (RGEN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Repligen Corp is 5.52%, while institutional ownership is 96.39%. The most recent insider transaction that took place on Sep 10 ’25, was worth 3,508,389. In this transaction Director of this company sold 29,111 shares at a rate of $120.52, taking the stock ownership to the 100,743 shares. Before that another transaction happened on Sep 10 ’25, when Company’s Director proposed sale 29,111 for $120.52, making the entire transaction worth $3,508,378.
Repligen Corp (RGEN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.44 earnings per share (EPS), higher than consensus estimate (set at 0.41) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.49% per share during the next fiscal year.
Repligen Corp (NASDAQ: RGEN) Trading Performance Indicators
Take a look at Repligen Corp’s (RGEN) current performance indicators. Last quarter, stock had a quick ratio of 7.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.20. Likewise, its price to free cash flow for the trailing twelve months is 81.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.03, a number that is poised to hit 0.44 in the next quarter and is forecasted to reach 2.10 in one year’s time.
Technical Analysis of Repligen Corp (RGEN)
Analysing the last 5-days average volume posted by the [Repligen Corp, RGEN], we can find that recorded value of 0.76 million was lower than the volume posted last year of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 47.06%.
During the past 100 days, Repligen Corp’s (RGEN) raw stochastic average was set at 72.20%, which indicates a significant increase from 46.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 7.37 in the past 14 days, which was higher than the 5.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $139.04, while its 200-day Moving Average is $134.38. Now, the first resistance to watch is $157.27. This is followed by the second major resistance level at $161.11. The third major resistance level sits at $167.08. If the price goes on to break the first support level at $147.46, it is likely to go to the next support level at $141.49. Now, if the price goes above the second support level, the third support stands at $137.65.
Repligen Corp (NASDAQ: RGEN) Key Stats
The company with the Market Capitalisation of 8.64 billion has total of 56,291K Shares Outstanding. Its annual sales at the moment are 634,440 K in contrast with the sum of -25,510 K annual income. Company’s last quarter sales were recorded 188,810 K and last quarter income was 14,910 K.
